These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2646838

  • 1. [Computer-assisted geometric measuring technic in coronary angiography interval studies: results of initial angiograms of the International Nifedipine Trial of Anti-atherosclerotic Therapy (INTACT) study].
    Jost S, Deckers J, Nellessen U, Rafflenbeul W, Hecker H, Reiber JH, Lippolt P, Hugenholtz PG, Lichtlen PR.
    Z Kardiol; 1989 Jan; 78(1):23-32. PubMed ID: 2646838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Jost S, Deckers JW, Nellessen U, Rafflenbeul W, Hecker H, Reiber JH, Hugenholtz PG, Lichtlen PR.
    Int J Card Imaging; 1988 Jan; 3(2-3):75-86. PubMed ID: 3049846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evolution of coronary stenoses is related to baseline severity--a prospective quantitative angiographic analysis in patients with moderate coronary disease. INTACT Investigators. International Nifedipine Trial on Antiatherosclerotic Therapy.
    Jost S, Deckers JW, Nikutta P, Wiese B, Rafflenbeul W, Hecker H, Lippolt P, Lichtlen PR.
    Eur Heart J; 1994 May; 15(5):648-53. PubMed ID: 8056005
    [Abstract] [Full Text] [Related]

  • 6. Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.
    Jost S, Deckers J, Rafflenbeul W, Reiber JH, Nikutta P, Wiese B, Hecker H, Lippolt P, Riedel M, Nolte CW.
    Int J Card Imaging; 1993 Mar; 9(1):29-37. PubMed ID: 8491998
    [Abstract] [Full Text] [Related]

  • 7. Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
    Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Nikutta P, Deckers JW.
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1047-68. PubMed ID: 2076392
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessment of the vasomotility of epicardial coronary arteries with quantitative coronary angiography.
    Jost S, Rafflenbeul W, Lichtlen P.
    Z Kardiol; 1989 Aug; 78 Suppl 6():143-8. PubMed ID: 2694662
    [Abstract] [Full Text] [Related]

  • 14. Quantitative coronary angiogram analysis: nifedipine retard versus angiotensin-converting enzyme inhibitors (JMIC-B side arm study).
    Shinoda E, Yui Y, Kodama K, Hirayama A, Nonogi H, Haze K, Sumiyoshi T, Hosoda S, Kawai C, Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group.
    Hypertension; 2005 Jun; 45(6):1153-8. PubMed ID: 15851624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.
    Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW.
    Lancet; 1990 May 12; 335(8698):1109-13. PubMed ID: 1971861
    [Abstract] [Full Text] [Related]

  • 17. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group.
    Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W.
    Circulation; 1992 Sep 12; 86(3):828-38. PubMed ID: 1516195
    [Abstract] [Full Text] [Related]

  • 18. The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results.
    Cashin-Hemphill L, Kramsch DM, Azen SP, DeMets D, DeBoer LW, Hwang I, Vailas L, Hirsch LJ, Mack WJ, DeBoer L.
    Online J Curr Clin Trials; 1992 Oct 23; Doc No 26():[9897 words; 83 paragraphs]. PubMed ID: 1343613
    [Abstract] [Full Text] [Related]

  • 19. Reproducible uniform coronary vasomotor tone with nitrocompounds: prerequisite of quantitative coronary angiographic trials.
    Jost S, Rafflenbeul W, Reil GH, Gulba D, Knop I, Hecker H, Lichtlen PR.
    Cathet Cardiovasc Diagn; 1990 Jul 23; 20(3):168-73. PubMed ID: 2114218
    [Abstract] [Full Text] [Related]

  • 20. [Ischemia tolerance of the heart in percutaneous transluminal coronary angioplasty. Controlled study of the effect of isosorbide dinitrate and nifedipine].
    Erbel R, Hüttemann M, Schreiner G, Darius N, Pop T, Meyer J.
    Herz; 1987 Aug 23; 12(4):302-11. PubMed ID: 2958398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.